The inability to consistently access sufficient and nutritious food affects an individual's ability to adhere to an obesity treatment plan, particularly given the importance of dietary modifications to optimize the benefits of GLP‐1 use, reduce nutrient shortfalls, and manage side effects. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.